27 years of historical data (1999–2025) · Healthcare · Medical - Healthcare Information Services
Percentile shows where the current value sits in 30-year historical distribution. Sparklines show 5-year trend.
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
HealthStream, Inc. trades at 42.0x earnings, 40% below its 5-year average of 70.0x, sitting at the 35th percentile of its historical range. Compared to the Healthcare sector median P/E of 22.1x, the stock trades at a premium of 90%. On a free-cash-flow basis, the stock trades at 12.6x P/FCF, 34% below the 5-year average of 19.0x.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $751M | $695M | $971M | $829M | $763M | $833M | $699M | $882M | $781M | $746M | $803M |
| Enterprise Value | $730M | $674M | $932M | $809M | $740M | $816M | $694M | $781M | $647M | $661M | $754M |
| P/E Ratio → | 42.03 | 37.82 | 48.18 | 54.06 | 63.69 | 146.44 | 49.64 | 61.82 | 24.15 | 74.71 | 208.75 |
| P/S Ratio | 2.47 | 2.29 | 3.33 | 2.97 | 2.86 | 3.25 | 2.85 | 3.47 | 3.37 | 3.01 | 3.55 |
| P/B Ratio | 2.18 | 1.96 | 2.70 | 2.43 | 2.28 | 2.46 | 2.09 | 2.61 | 2.45 | 2.48 | 2.81 |
| P/FCF | 12.60 | 11.66 | 32.91 | 13.42 | 15.44 | 21.39 | 20.62 | 20.20 | 31.49 | 25.86 | 85.20 |
| P/OCF | 11.87 | 10.98 | 16.85 | 12.96 | 14.91 | 19.66 | 19.47 | 13.43 | 18.06 | 15.96 | 33.15 |
P/E links to full P/E history page with 30-year chart
Enterprise-value multiples — capital-structure-neutral measures of total business value
HealthStream, Inc.'s enterprise value stands at 11.5x EBITDA, 21% below its 5-year average of 14.5x. The Healthcare sector median is 14.2x, placing the stock at a 19% discount on an enterprise-value basis.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 2.22 | 3.20 | 2.90 | 2.77 | 3.18 | 2.83 | 3.07 | 2.79 | 2.67 | 3.34 |
| EV / EBITDA | 11.46 | 10.58 | 14.90 | 14.17 | 14.69 | 18.18 | 15.08 | 18.34 | 16.28 | 19.53 | 27.14 |
| EV / EBIT | 36.07 | 29.03 | 43.78 | 50.50 | 59.47 | 101.26 | 43.87 | 53.07 | 41.74 | 70.26 | 122.59 |
| EV / FCF | — | 11.30 | 31.57 | 13.10 | 14.98 | 20.93 | 20.48 | 17.89 | 26.08 | 22.92 | 79.94 |
Margins and return-on-capital ratios measuring operating efficiency
HealthStream, Inc. earns an operating margin of 6.7%. ROE of 5.1% is modest. ROIC of 4.7% represents below-average returns on invested capital.
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 64.7% | 64.7% | 66.4% | 66.0% | 65.8% | 64.5% | 63.5% | 59.1% | 58.5% | 57.2% | 57.2% |
| Operating Margin | 6.7% | 6.7% | 7.3% | 5.7% | 4.7% | 3.1% | 6.5% | 5.8% | 6.7% | 4.0% | 2.5% |
| Net Profit Margin | 6.0% | 6.0% | 6.9% | 5.5% | 4.5% | 2.3% | 5.8% | 6.2% | 13.9% | 4.0% | 1.7% |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | 5.1% | 5.1% | 5.7% | 4.5% | 3.6% | 1.7% | 4.2% | 4.8% | 10.4% | 3.4% | 1.3% |
| ROA | 3.6% | 3.6% | 4.0% | 3.0% | 2.5% | 1.2% | 2.8% | 3.4% | 7.6% | 2.5% | 1.0% |
| ROIC | 4.7% | 4.7% | 5.0% | 3.8% | 3.0% | 1.9% | 4.2% | 5.2% | 5.8% | 3.3% | 1.9% |
| ROCE | 5.1% | 5.1% | 5.5% | 4.2% | 3.2% | 2.1% | 4.1% | 4.1% | 4.8% | 3.2% | 1.9% |
Solvency and debt-coverage ratios — lower is generally safer
HealthStream, Inc. carries a Debt/EBITDA ratio of 0.2x, which is very conservative (93% below the sector average of 3.2x). The company holds a net cash position — cash of $36M exceeds total debt of $15M, providing substantial financial flexibility for buybacks, acquisitions, or weathering downturns.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.04 | 0.04 | 0.06 | 0.06 | 0.07 | 0.09 | 0.10 | 0.09 | — | — | — |
| Debt / EBITDA | 0.23 | 0.23 | 0.32 | 0.35 | 0.46 | 0.65 | 0.69 | 0.72 | — | — | — |
| Net Debt / Equity | — | -0.06 | -0.11 | -0.06 | -0.07 | -0.05 | -0.01 | -0.30 | -0.42 | -0.28 | -0.17 |
| Net Debt / EBITDA | -0.34 | -0.34 | -0.63 | -0.35 | -0.45 | -0.40 | -0.10 | -2.37 | -3.38 | -2.50 | -1.79 |
| Debt / FCF | — | -0.36 | -1.33 | -0.33 | -0.46 | -0.46 | -0.14 | -2.31 | -5.42 | -2.94 | -5.26 |
| Interest Coverage | — | — | — | — | — | — | — | — | — | — | — |
Net cash position: cash ($36M) exceeds total debt ($15M)
Short-term solvency ratios and asset-utilisation metrics
The current ratio of 0.96x is below 1.0, meaning current liabilities exceed current assets. The current ratio has declined from 1.10x to 0.96x over the past 3 years.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 0.96 | 0.96 | 1.32 | 1.10 | 0.98 | 1.06 | 0.96 | 2.14 | 2.30 | 1.98 | 1.87 |
| Quick Ratio | 0.96 | 0.96 | 1.32 | 1.10 | 0.98 | 1.06 | 0.96 | 2.14 | 2.30 | 1.98 | 1.87 |
| Cash Ratio | 0.46 | 0.46 | 0.84 | 0.60 | 0.46 | 0.52 | 0.39 | 1.64 | 1.61 | 1.30 | 1.09 |
| Asset Turnover | — | 0.58 | 0.57 | 0.56 | 0.54 | 0.53 | 0.49 | 0.52 | 0.53 | 0.60 | 0.57 |
| Inventory Turnover | — | — | — | — | — | — | — | — | — | — | — |
| Days Sales Outstanding | — | 46.81 | 44.21 | 50.29 | 58.42 | 49.65 | 68.73 | 43.63 | 64.62 | 56.03 | 76.54 |
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
HealthStream, Inc. returns 4.5% to shareholders annually — split between a 0.5% dividend yield and 4.0% buyback yield. The payout ratio of 20.3% is conservative, leaving significant room for dividend growth or reinvestment. The earnings yield of 2.4% (inverse of P/E) provides a useful comparison to bond yields when assessing the stock's relative attractiveness to fixed income.
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Yield | 0.5% | 0.5% | 0.4% | 0.4% | — | 0.0% | 0.0% | 0.0% | 4.1% | — | — |
| Payout Ratio | 20.3% | 20.3% | 17.0% | 20.1% | — | 0.3% | 0.3% | 0.4% | 100.4% | — | — |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Yield | 2.4% | 2.6% | 2.1% | 1.8% | 1.6% | 0.7% | 2.0% | 1.6% | 4.1% | 1.3% | 0.5% |
| FCF Yield | 7.9% | 8.6% | 3.0% | 7.5% | 6.5% | 4.7% | 4.9% | 4.9% | 3.2% | 3.9% | 1.2% |
| Buyback Yield | 4.0% | 4.3% | 0.1% | 1.2% | 3.1% | 0.7% | 2.9% | 0.1% | 0.0% | 0.1% | 0.0% |
| Total Shareholder Yield | 4.5% | 4.9% | 0.5% | 1.6% | 3.1% | 0.7% | 2.9% | 0.1% | 4.2% | 0.1% | 0.0% |
| Shares Outstanding | — | $30M | $31M | $31M | $31M | $32M | $32M | $32M | $32M | $32M | $32M |
Compare HSTM with 10 similar companies in its peer group
| Company | Market Cap | P/E | EV/EBITDA | P/FCF | Gross Margin | Op Margin | ROE | ROIC | Debt/EBITDA |
|---|---|---|---|---|---|---|---|---|---|
| $751M | 42.0 | 11.5 | 12.6 | 64.7% | 6.7% | 5.1% | 4.7% | 0.2 | |
| $922M | 31.2 | 4.2 | 5.6 | 92.8% | 11.0% | 4.5% | 10.6% | 0.3 | |
| $25B | 28.2 | 19.7 | 18.0 | 75.5% | 28.7% | 13.9% | 12.9% | 0.1 | |
| $129M | -0.7 | 17.3 | — | 33.5% | -11.6% | -58.3% | -6.1% | 11.9 | |
| $4B | 20.9 | 16.8 | — | 89.1% | 33.3% | 19.3% | 19.8% | 0.0 | |
| $67M | -0.5 | 6.1 | 2.9 | 73.7% | -7.6% | -439.6% | -5.7% | 6.5 | |
| $2B | 6.8 | 6.8 | 8.5 | 72.3% | 38.5% | 29.1% | 14.2% | 1.3 | |
| $3B | 53.6 | 23.1 | 13.8 | 54.0% | 5.7% | 8.8% | 5.1% | 3.0 | |
| $7B | 15.5 | 8.9 | 16.7 | 78.6% | 27.6% | 27.4% | 30.7% | 0.2 | |
| $84B | 13.2 | 8.6 | 10.9 | 41.5% | 15.8% | — | 19.9% | 3.2 | |
| $141M | -1.4 | — | — | 53.3% | -42.2% | -33.9% | -95.1% | — | |
| Healthcare Median | — | 22.1 | 14.2 | 18.5 | 63.9% | -4.3% | -32.6% | -11.6% | 3.2 |
Peer selection based on competitive and market overlap. Compare multiple stocks →
Includes 30+ ratios · 27 years · Updated daily
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
See how regular investing compounds over time.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying HSTM stock.
HealthStream, Inc.'s current P/E ratio is 42.0x. The historical average is 56.4x. This places it at the 35th percentile of its historical range.
HealthStream, Inc.'s current EV/EBITDA is 11.5x. This enterprise value multiple compares the company's total value (equity + debt - cash) to its EBITDA. The historical average is 19.9x.
HealthStream, Inc.'s return on equity (ROE) is 5.1%. The historical average is -1.4%.
Based on historical data, HealthStream, Inc. is trading at a P/E of 42.0x. This is at the 35th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.
HealthStream, Inc.'s current dividend yield is 0.48% with a payout ratio of 20.3%.
HealthStream, Inc. has 64.7% gross margin and 6.7% operating margin.
HealthStream, Inc.'s Debt/EBITDA ratio is 0.2x, indicating low leverage. A ratio below 2x is generally considered financially healthy.